Antibiotics
| Catalog | Product Name / CAS / Description | Structure |
|---|---|---|
| BBF-02485 | ||
SS-56D is an aminoglycoside antibiotic produced by Streptomyces eurocidicus. It exhibits activity against gram-positive and gram-negative bacteria. |
||
| BBF-02492 | ||
TAN-950A is an antifungal produced by Streptomyces platensis A-136. It is effective against Candida with MIC of 0.78-3.13 μg/mL. |
||
| BBF-02495 | ||
TAN-1057A is an antibiotic produced by Flexibacter sp. PK-74 and PK-176. It is active against Gram-negative and Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus. It inhibited protein biosynthesis in Escherichia coli and S. aureus. |
||
| BBF-02496 | ||
TAN-1057B is an antibiotic produced by Flexibacter sp. PK-74 and PK-176. It is active against Gram-negative and Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus. |
||
| BBF-02497 | ||
TAN-1057C is an antibiotic produced by Flexibacter sp. PK-74 and PK-176. It is active against Gram-negative and Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus. |
||
| BBF-02498 | ||
TAN-1057D is an antibiotic produced by Flexibacter sp. PK-74 and PK-176. It is active against Gram-negative and Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus. |
||
| BBF-02500 | ||
TAN-1323C is a concanamycin-group antibiotic produced by Streptomyces purpurascens. It showed remarkably potent angiostatic activity in the chick chorioallantoic membrane (CAM) assay. |
||
| BBF-02501 | ||
TAN-1323D is a concanamycin-group antibiotic produced by Streptomyces purpurascens. It showed remarkably potent angiostatic activity in the chick chorioallantoic membrane (CAM) assay. |
||
| BBF-02513 |
Vioxanthin (15447-05-9) Inquiry |
|
Vioxanthin is an antibiotic produced by Malbranchea pulchella var. sulfurea. It is active against gram-positive bacteria and bacteroides fragilis. |
||
| BBF-02514 | ||
TL-119 is an antibiotic isolated from Bacillus subtilis. It is effective against gram-positive bacteria and fungi. |
||
| BBF-02515 | ||
TMC-1A is a Manumycin-associated antibiotic produced by Streptomyces sp. A-230. It has activity against gram-positive bacteria and cytotoxicity to various cancer cells. |
||
| BBF-02516 | ||
TMC-1B is a Manumycin-associated antibiotic produced by Streptomyces sp. A-230. It has activity against gram-positive bacteria and cytotoxicity to various cancer cells. |
||
| BBF-02517 | ||
TMC-1C is a Manumycin-associated antibiotic produced by Streptomyces sp. A-230. It has activity against gram-positive bacteria and cytotoxicity to various cancer cells. |
||
| BBF-02518 | ||
TMC-1D is a Manumycin-associated antibiotic produced by Streptomyces sp. A-230. It has activity against gram-positive bacteria and cytotoxicity to various cancer cells. |
||
| BBF-02522 | ||
TMC-34 is an macrolide antifungal antibiotic produced by Streptomyces sp. A-3030. |
||
| BBF-02550 | ||
TPU-0031-A is an antibiotic of the novobiocin group produced by Streptomyces sp. TP-A0556. It shows antibiotic activity against Gram-positive and -negative bacteria. |
||
| BBF-02551 | ||
TPU-0031-B is an antibiotic of the novobiocin group produced by Streptomyces sp. TP-A0556. It shows antibiotic activity against Gram-positive and -negative bacteria. |
||
| BBF-02552 | ||
TPU-0037B is a lydicamycin congener with anti-MRSA activity isolated from a culture broth of an actinomycete strain. It is closely related to BN 4515N which was isolated from a strain of microtetraspora as a neuritogenic agent. |
||
| BBF-02553 | ||
TPU-0037D is a lydicamycin congener with anti-MRSA activity isolated from a culture broth of an actinomycete strain. It is closely related to BN 4515N which was isolated from a strain of microtetraspora as a neuritogenic agent. |
||
| BBF-02554 | ||
U-20904 is an antibiotic produced by Actinomycetes. It exhibits activity against Blastomycetes dermatitis and KB cells. |
